Jun 16, 2020
FDA Approves First Treatment for Adult Onset Still's Disease, a Severe and Rare Disease
Jun 16, 2020
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
Jun 16, 2020
Cardinal Health Rheumatology Insights: New Research Shows Rheumatologists See Telemedicine, Advanced Practice Providers as Keys to Managing Growing Demand for Care
Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 11, 2020
GSK Consumer Healthcare teams up with Paula Abdul for the launch of Voltaren Arthritis Pain Gel
Jun 06, 2020
AbbVie Presents Data Showing RINVOQ(TM) (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients
Jun 03, 2020
EULAR 2020: Lilly's Taltz® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis
Jun 01, 2020
Lilly's Taltz® (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Jun 01, 2020
AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ(TM) (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
May 27, 2020
AbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfolio
May 21, 2020
Global Market Report on Fibromyalgia Market 2020: Featuring Allergan, Axome and Pfizer
May 21, 2020
OrthogenRx Announces Response in The Journal of Bone and Joint Surgery
May 13, 2020
Global Fibromyalgia Market, Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares (2016-2024)
May 12, 2020
TPX-100: OrthoTrophix Presents More Evidence for Disease Modification in Knee Osteoarthritis in a New Abstract Published in Osteoarthritis & Cartilage Journal
Apr 24, 2020
Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Apr 15, 2020
Mallinckrodt Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy
Apr 10, 2020
Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets(TM)
Apr 09, 2020
Hydroxychloroquine, Lupus and COVID-19: What We've Learned and What's Next?
Apr 07, 2020
Lupus Therapeutics, Affiliate Of Lupus Research Alliance, Developing A Study Focused On Lupus Patients And COVID-19
Apr 06, 2020
The Lancet Simultaneously Publishes Two Phase 3 Studies Detailing Comprehensive Efficacy and Safety of TREMFYA® (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, in Psoriatic Arthritis